Industry news focusing on the people and organizations who work in the clinical trials profession.
Medical Research Network (Buckinghamshire, UK) announced the hire of three more healthcare professionals. Sheetal Kumar joined as a Research Nurse Manager; Laurie James joined as a Project Manager; and Helen Marks, PhD, joined the Vendor & Contracts Management Team.
Packaging Coordinators, Inc. (PCI) (Philadelphia, PA) announced the addition of Tim Brown to its Global Clinical Services staff, assuming the role of Director of Project Management for North American Operations.
Biotec Services International (Bridgend, UK) announced the appointment of Ashley Cooper—Founder and Chief Executive Officer of TES Aviation Group—to its Board of Directors.
Celerion (Lincoln, NE) announced the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Chew Lan Chong, MBBS, MCRS, MSc, as Executive Director, Medical Research.
Certara (St. Louis, MO) announced Edmundo Muniz, MD, PhD, MS, has been appointed its new Chief Executive Officer.
CSSi (Glen Burnie, MD) announced the formation of the company’s Medical and Clinical Advisory Board, and the appointment of Ronald M. Bukowski, MD, as its chairman.
CTI Clinical Trial and Consulting Services (Cincinnati, OH) announced Joseph M. McCafferty has been promoted to Vice President, Sales North America, leading the sales team as it continues to grow and expand to geographies across the globe.
Clinipace Worldwide (Morrisville, NC) announced the addition of Roger Morgan, MD, FACS, as Executive Vice President, Global Medical Affairs.
Pharmaceutical Product Development (PPD) (Wilmington, NC) announced that it has been selected as one of the most innovative organizations using information technology to create business value by CIO magazine’s 27th annual CIO 100 Awards.
Moderna’s mRNA-1010 Flu Vaccine Meets Efficacy Goals in Phase III Trial of Adults 50+
July 10th 2025In the P304 Phase III study, Moderna’s mRNA-1010 demonstrated a 26.6% relative efficacy over a standard-dose flu vaccine in adults aged 50+, showing consistent protection across strains and age groups.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.